Rua Life Sciences Share Discussion Threads

[purple11] 30/10/2024 12:33

Zico the Clown STRIKES AGAIN!

[cocker] 30/10/2024 11:44

Well I'm afraid as much as you want to believe that the company is undervalued, the market has reacted differently and that's a fact. HV was just like the graphs a possible golden ticket, now we find out its simply not, or they would have been all over it. Failure is Williams middle name and not even Bones can be prepared to comment on the dire news once again.

[z1co] 30/10/2024 11:05

More facts;

The gross assets of Abiss at 31 December 2023 were €2,265,000. Revenue in the year to 31 December 2023 was €2,159,000 up 36% from €1,592,000 during 2023. Loss before tax was €352,000 after depreciation and amortisation charges of €537,000. In the year to 31 December 2023, Abiss had net positive cash flow of €223,000 and cash balances of €279,000 at the year end. Net Assets/Shareholders Funds at 31 December 2023 were €1,624,000. Non-current liabilities totalled €640,000 at 31 December 2023.

Bill Brown, stated: "There are many similarities between Abiss and RUA Contract Manufacture, particularly with a shared customer. Abiss has been pursuing contract manufacture opportunities to further grow its business and the combined strengths of RUA and Abiss should only increase the potential. We very much look forward to working with the Abiss team and integrating into the RUA group."

[turbotrader2] 30/10/2024 10:23

Bitter are we?

[z1co] 30/10/2024 10:04

Traders selling on good news as usual!

The business is beginning to gain real traction , revenue for the full year will increase significantly over last year , the purchase of Abiss Group for only 80,000 euro's was a bargain and will contribute strongly in H2 and going forward.

At 30th September they had £3.5m cash and valued at less than £8m , shares are seriously undervalued.

[cocker] 30/10/2024 08:59

Totally agree H. The long line of commercial failures here says it all really. Bill Brown is simply not fit for purpose , just like many of the products he claims are world beaters and yet never come to fruition, unlike the regular fund raises of which some were said not to be coming. So once again, many of the new investors here are starting to learn the hard way with regards to the "Champion of failures", arise Sir William Brown.

[z1co] 30/10/2024 08:33

At the AGM in August the company was expecting total revenue for the 6 months to end September to exceed £1.2m.

The revenue of £1.485m reported today is well ahead of that number.

With material revenue from Abiss Group to come , H2 and 2025 is looking very positive

[rivaldo] 30/10/2024 08:26

Today's a difficult day to make judgements based on share price reactions - it could just be one or two investors taking profits from the 10.5p-11p area before the Budget changes later on. Or perhaps someone wedded to success re the heart valve has exited given the comment about the MTA partner's priorities.

Personally I'm happiest to see the core trading business apparently thriving with the more speculative elements an added and potentially huge bonus.

I see it's started to bounce now anyway.

[harrogate] 30/10/2024 08:20

Not good at all for me as the HV material potential partner is no such thing. I am here for the HV and I guess that we are much further away from monetising that. Another in the long line of commercial failures here. 25 years worth in fact. If you are here to see them try to build a small medical device contract manufacturer then there is some good news

[7767] 30/10/2024 08:17

Why this reaction to the announcement????

[rivaldo] 30/10/2024 07:57

Today's update looks good to me.

And a £0.4m PBT in H1! OK, this is mostly due to the £0.9m gain on the Abiss acquisition, but this just shows what a bargain this was. And the £0.5m loss before the Abiss gain is a vast improvement anyway.

With £3.5m net cash and core profitability expected to March'26 (before the changed accounting reference date) RUA look in an excellent position to fully exploit any good news coming out of the Vascular and Heart technologies.

[unionhall] 24/10/2024 09:11

Strange reverse in share price today....

[thiopia] 17/10/2024 15:53

The Acquisition has not completed yet. Due Diligence being undertaken.

[7767] 17/10/2024 15:38

Can't understand this lack of support after the great acquisition made.

[7767] 17/10/2024 15:30

Can't understand this lack of support after the great acquisition made.

[spawny100] 11/10/2024 10:35

Can't see it being II interest buying right now as volume too small. Doesn't seem like they're keen on buyers though and reckon brakes will come off once someone pays 16p.

[early not wrong] 11/10/2024 09:47

I'm expecting a bit of chop as a bit of supply comes onto the market as it moves up from here, but judging on past volumes in the next range, it doesn't look like it will be dragged back for too long as current demand is so strong and one way. It looks like professional (institutional) accumulation to me and long may it continue!
This is a different business now.

[davisc5] 11/10/2024 08:02

The chart certainly looks nice, could move past 20p pretty quickly

[obiterdicta] 11/10/2024 06:05

Winter is coming. The bulletin board's bears are hibernating.